Press Releases
Press Releases
ChargePoint Technology Launches First-of-its-kind Smart Monitoring Technology at ACHEMA 2018
Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has launched a unique Smart monitoring hub to support efficiency and safety within chemical and pharmaceutical manufacturing processes. The company will be exhibiting its new VERIFI solution...
Press Releases
CRF Healthโs eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company
CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its electronic Clinical Outcome Assessment (eCOA) solutions have been selected for a significant insomnia trial by a European pharmaceutical company specializing in the discovery...
Press Releases
WuXi STA Changzhou Site Passes First U.S. FDA Inspection
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, announces that its active pharmaceutical ingredient (API) R&D and manufacturing facility located in Changzhou, China has secured Pre-Approval Inspection (PAI) for two APIs from the U.S. FDA โ with no...
Press Releases
Largest-ever HKTDC Hong Kong International Medical Fair Opens
Organised by HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association, the ninth edition of the HKTDC Hong Kong International Medical Devices and Supplies Fair opened today and continues through 9 May at the Hong...
Press Releases
Professional LAB Marketplace for Asia โ Thailand LAB INTERNATIONAL 2018
The 8thInternational Trade Exhibition and Conference on Analytical Laboratory Equipment & Technology, Biotechnology & Life Sciences and Chemical & Safety will return again during 12thโ 14thSeptember 2018 at EH102-103, BITEC, Thailand.ย Last year Thailand LAB INTERNATIONAL...
Press Releases
Lonza to Host New Webinar: โEngineering Culture Platforms to Mimic Liver Diseasesโ
On 16 May 2018, Lonza is hosting a free 60-minute webinar on innovative technologies for building advanced human liver culture platforms that better mimic common liver diseases, such as non-alcoholic fatty liver disease, liver fibrosis and hepatitis B viral...
Press Releases
Biogen and Neurimmune Announce Option Exercise for Alzheimerโs Disease Investigational Treatment Aducanumab
Biogen and Neurimmune announced that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales of aducanumab, Biogenโs Phase 3 investigational treatment for early Alzheimerโs disease. Biogen will...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.














